Effect Of Baseline Medications On Response To Immunotherapy In Hepatocellular Carcinoma
JOURNAL OF CLINICAL ONCOLOGY(2020)
摘要
484Background: Immunotherapy (IO) response rates in advanced hepatocellular carcinoma (HCC) are less than 20%. The microbiome has been shown to mediate IO response in experimental models, and clini...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要